What You Should Know:
- Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer.
- This partnership combines Absci's cutting-edge Integrated Drug Creation™ platform with AstraZeneca's oncology expertise, aiming to accelerate the discovery of a potential new cancer treatment.
Absci's AI Engine Takes the Lead
Absci will leverage
Read More
Intuitive Ventures Closes $150M Fund to Fuel Revolution in Minimally Invasive Care
What You Should Know:
- Intuitive Ventures, an early-stage venture capital fund dedicated to reimagining minimally invasive care, announced the close of its second fund at $150M.
- The funding signifies their unwavering commitment to supporting visionary founders who are transforming healthcare through precision diagnostics, secure digital ecosystems, and improved access to coordinated care.
Building on a Strong Foundation
In 2020, Intuitive Ventures launched its inaugural fund of
Read More
Potrero Medical Files for Chapter 11 Bankruptcy, Aims to Reorganize and Refocus on Patient Care
What You Should Know:
- Potrero Medical, Inc., a company developing innovative solutions for monitoring and improving kidney health, announced today it has filed for Chapter 11 bankruptcy.
- The restructuring process is expected to be completed within 75 days, according to the company. Potrero believes this strategic move will strengthen its financial footing and enable it to continue its mission of elevating patient care through innovative technologies.
Focusing on Patient-Centric
Read More
RSNA23: AI-Powered Brain Scans May Aid in ADHD Diagnosis, Research Reveals
What You Should Know:
- Using artificial intelligence (AI) to analyze specialized brain MRI scans of adolescents with and without attention-deficit/hyperactivity disorder (ADHD), researchers found significant differences in nine brain white matter tracts in individuals with ADHD. The results of the study will be presented today at the annual meeting of the Radiological Society of North America (RSNA).
ADHD: A Common and Challenging Disorder
ADHD is a common neurodevelopmental disorder
Read More
HFMA and FinThrive Launch Revenue Cycle Management Technology Adoption Model
What You Should Know:
- The Healthcare Financial Management Association (HFMA) has announced a strategic alliance with FinThrive, Inc., a healthcare revenue cycle management (RCM) software-as-a-service (SaaS) provider, to co-launch a peer-reviewed, five-stage Revenue Cycle Management Technology Adoption Model (RCMTAM).
- The RCMTAM is designed to help health systems leverage industry benchmarks to assess their current state of RCM technology maturity and build best-practice plans to
Read More
Clover Health Exits CMS ACO REACH Program to Focus on Medicare Advantage
What You Should Know:
- Clover Health, a physician enablement company committed to bringing access to great healthcare to everyone on Medicare announced that it has delivered notice to the Centers for Medicare and Medicaid Services (“CMS”) that it will exit the CMS ACO REACH Program at the end of the 2023 performance year.
- Written notification will also be sent to all participating physicians in accordance with CMS requirements.
- The decision will have no impact on its ACO REACH
Read More
Lunit, NTT DATA Partner to Deploy AI-Powered Chest X-Ray Solution in Singapore
What You Should Know:
- Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has partnered with NTT DATA Singapore to introduce Lunit INSIGHT CXR at Singapore General Hospital (SGH) and Changi General Hospital (CGH), two of Singapore's largest public hospitals.
- Lunit INSIGHT CXR is an AI-powered solution that helps radiologists detect abnormalities in chest X-ray images. The deployment of Lunit INSIGHT CXR at SGH and CGH is expected to improve the efficiency
Read More
Vivodyne Secures $38M for AI-Powered Drug Discovery Platform
What You Should Know:
- Vivodyne, a biotech company that accelerates drug discovery by testing therapies on lab-grown human organs raises $38M in total seed financing, led by Khosla Ventures, with participation from Kairos Ventures, CS Ventures, MBX Capital, and Bison Ventures.
- The funding will support Vivodyne's development of a clinically predictive AI stack and discovery pipeline, which utilizes lab-grown human organ tissues to identify novel therapeutic targets and predict patient
Read More
RSNA23: Nuance Pioneers Generative AI in Radiology with PowerScribe Advanced Auto Impression
What You Should Know:
- Nuance Communications, Inc., a Microsoft Company, announced significant advancements in its efforts to empower radiologists with the latest generative AI capabilities.
- At RSNA23, the company unveiled PowerScribe Smart Impression, a revolutionary AI-powered solution that streamlines workflows, accelerates reporting, and enhances efficiency for radiologists amidst growing staffing shortages and clinician burnout.
PowerScribe Smart Impression: Enhancing Reporting
Read More
Cigna and Humana Merger Talks Could Face Antitrust Scrutiny
What You Should Know:
- Cigna and Humana are in talks to merge in a deal that would create a US health insurance giant worth $140B and provide a significant test for antitrust authorities.
- A combination between Cigna and Humana would help the companies compete with larger rivals such as UnitedHealth Group and Elevance Health, formerly known as Anthem. The two companies have hired advisers who have been discussing a cash and stock deal for more than a month. They hope to get the
Read More
